Español
|
English
BUSCADOR
CIBER
INTRANET
LINKS
WEBMAIL
Toggle navigation
MENÚ
About Us
Welcome from the Scientific Director
Mission and objectives
Structure
Steering Committee
External Scientific Advisory Committee (ESAC)
Governing Board
Permanent Commission
Consortium Institutions
Head Office
Thematic Areas
Information Resources
Contact
Groups
Research Groups
Clinical Linked Groups
Geographical Distribution
Research Programmes
P1. Mechanism of liver damage, evolution and progression of cirrhosis and liver transplantation.
P2: Gastrointestinal pathophysiology: inflammatory disease and motility disorders.
P3: Hepatic and digestive oncology
Transversal Programs
Training programme
Communication Programme
Internationalisation Programme
Platforms
Biobanks
Biobanc Clinic
Collection of Steatotic livers
Bioinformatics
CIC bioGUNE. Platform for Genomics, Proteomics, Metabolomics and Gene Silencing
Technology Offer
Press
Events
CIBER Newsletter
CIBEREHD Newsletter
Previous Newsletter
Platforms
Technology Offer
Technology Offer
Technology range of the
CIBEREHD:
Biosignatures for ulcerative colitis
Non-invasive method for the diagnosis of colorectal cancer
Saliva-based diagnostic test for eosinophilic oesophagitis
Informative biomarkers of portal hypertension.
Compounds for treating Helicobacter pylori and Campylobacter jejuni infection.
Saliva-based diagnostic test for eosinophilic oesophagitis
Saliva-based diagnostic test for eosinophilic oesophagitis
Predictive method of anti-TNF-alpha therapy response in patients with Crohn´s disease
Biobanks
Biobanc Clinic
Collection of Steatotic livers
Bioinformatics
CIC bioGUNE. Platform for Genomics, Proteomics, Metabolomics and Gene Silencing
Technology Offer
